CRANBURY, N.J.–(BUSINESS WIRE)–Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today announced that the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation to RP-A601, the Company’s investigational adeno-associated virus (AAV)-based gene therapy … [Read more…]

Final data from a first-of-its-kind clinical trial confirm that the combination of Sculptra® and Restylane® Lyft™ or Contour™* delivers sustained improvement in facial aesthetic appearance for patients experiencing facial volume loss due to medication-driven weight loss1 Following interim analysis at three months presented earlier this year, a six-month extension study was conducted to capture the … [Read more…]

WASHINGTON–(BUSINESS WIRE)–AIDS Healthcare Foundation (AHF) today praised the U.S. Senate for its bipartisan decision to preserve funding for the President’s Emergency Plan for AIDS Relief (PEPFAR), a program credited with saving over 25 million lives globally since it was launched under President George W. Bush. Lawmakers removed a proposed $400 million cut to PEPFAR. The … [Read more…]

Actress and Real-Life Invisalign User Julia Butters Joins the Highly Anticipated Movie Sequel and Co-Promotional Campaign TEMPE, Ariz.–(BUSINESS WIRE)–Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, today announced a collaboration with Disney’s highly anticipated movie sequel “Freakier Friday,” which opens … [Read more…]

Based in San Francisco and London, Prima Mente is building AI-native infrastructure for molecular biology and neurodegenerative disease research. Its models integrate genomic, epigenomic, and proteomic data to power biomarker discovery, diagnostics, and translational R&D The company announces its first family of models, Pleiades. Focussing on human epigenetics, the model accurately determines cell type of … [Read more…]

Late-Breaking Results from EMBO-02 Clinical Trial Presented at the Society of Neurointerventional Surgery Annual Meeting WALTHAM, Mass.–(BUSINESS WIRE)–Arsenal Medical, a clinical-stage company developing innovative biomaterials-based devices, today announced late-breaking data from the EMBO-02 clinical study for NeoCast™, a next-generation, shear-responsive liquid embolic treatment. In EMBO-02, NeoCast was evaluated in patients with chronic subdural hematoma (cSDH), … [Read more…]

The significant philanthropic support comes at a time of uncertainty for federal research funding The grants will support new approaches to the deadliest cancer, from novel early detection methods, using AI to identify those with higher risk, and new immunotherapy treatments LOS ANGELES–(BUSINESS WIRE)–The Stephenson Global Pancreatic Cancer Research Institute and its partner City of … [Read more…]

Wednesday, August 13, 2025 at 9:00 am Eastern Time LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that the Company will participate at the Canaccord Genuity 45th Annual Growth Conference in Boston. Management is scheduled to present on Wednesday, August 13, 2025 at 9:00 am Eastern Time. Interested parties … [Read more…]

LONDON–(BUSINESS WIRE)–Ryan, a leading global tax services and software provider, has been named one of the United Kingdom’s Best Workplaces for Wellbeing™ by Great Place To Work®, ranking 31 in the Medium Company category on this year’s list. Companies recognised on this prestigious list have consistently placed team member wellbeing at the heart of their … [Read more…]

– First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients – 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI – Topline results expected in the second half of 2026 LILLE, France & PARIS–(BUSINESS WIRE)–4Moving Biotech (4MB), … [Read more…]